Montag A & Associates Inc Pfizer Inc Transaction History

Montag A & Associates Inc

  • $2.09 Billion
  • Q3 2024

A detailed history of Montag A & Associates Inc transactions in Pfizer Inc stock. As of the latest transaction made, Montag A & Associates Inc holds 80,472 shares of PFE stock, worth $2.11 Million. This represents 0.11% of its overall portfolio holdings.

Number of Shares
80,472
Previous 81,151 0.84%
Holding current value
$2.11 Million
Previous $2.27 Million 2.56%
% of portfolio
0.11%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 05, 2024
SELL
$27.7 - $31.39 $18,808 - $21,313
-679 Reduced 0.84%
80,472 $2.33 Million
Q2 2024

Jul 31, 2024
SELL
$25.26 - $29.6 $193,011 - $226,173
-7,641 Reduced 8.61%
81,151 $2.27 Million
Q1 2024

May 07, 2024
SELL
$25.89 - $29.73 $620,764 - $712,836
-23,977 Reduced 21.26%
88,792 $2.46 Million
Q4 2023

Feb 07, 2024
SELL
$26.13 - $33.94 $63,495 - $82,474
-2,430 Reduced 2.11%
112,769 $3.25 Million
Q3 2023

Nov 09, 2023
SELL
$32.09 - $37.51 $279,022 - $326,149
-8,695 Reduced 7.02%
115,199 $3.82 Million
Q2 2023

Aug 09, 2023
BUY
$36.12 - $41.79 $26,223 - $30,339
726 Added 0.59%
123,894 $4.54 Million
Q1 2023

May 11, 2023
BUY
$39.39 - $51.28 $74,959 - $97,585
1,903 Added 1.57%
123,168 $5.03 Million
Q4 2022

Feb 02, 2023
SELL
$41.75 - $54.5 $97,903 - $127,802
-2,345 Reduced 1.9%
121,265 $6.22 Million
Q3 2022

Nov 09, 2022
BUY
$43.76 - $53.42 $56,712 - $69,232
1,296 Added 1.06%
123,610 $5.41 Million
Q2 2022

Aug 10, 2022
SELL
$46.53 - $55.17 $75,378 - $89,375
-1,620 Reduced 1.31%
122,314 $6.41 Million
Q1 2022

May 02, 2022
SELL
$45.75 - $56.69 $28,090 - $34,807
-614 Reduced 0.49%
123,934 $6.42 Million
Q4 2021

Feb 09, 2022
SELL
$41.32 - $61.25 $253,580 - $375,891
-6,137 Reduced 4.7%
124,548 $7.35 Million
Q3 2021

Nov 08, 2021
SELL
$39.25 - $50.42 $253,672 - $325,864
-6,463 Reduced 4.71%
130,685 $5.62 Million
Q2 2021

Aug 03, 2021
BUY
$35.91 - $40.68 $6,715 - $7,607
187 Added 0.14%
137,148 $5.37 Million
Q1 2021

May 14, 2021
SELL
$33.49 - $37.77 $248,763 - $280,555
-7,428 Reduced 5.14%
136,961 $4.96 Million
Q4 2020

Feb 12, 2021
BUY
$33.47 - $42.56 $125,746 - $159,897
3,757 Added 2.67%
144,389 $5.32 Million
Q3 2020

Nov 12, 2020
SELL
$31.75 - $37.25 $65,881 - $77,293
-2,075 Reduced 1.45%
140,632 $5.16 Million
Q2 2020

Aug 04, 2020
SELL
$30.12 - $36.54 $13,855 - $16,808
-460 Reduced 0.32%
142,707 $4.67 Million
Q1 2020

May 06, 2020
SELL
$27.03 - $38.62 $192,453 - $274,974
-7,120 Reduced 4.74%
143,167 $4.67 Million
Q4 2019

Feb 05, 2020
SELL
$32.92 - $37.36 $183,430 - $208,169
-5,572 Reduced 3.58%
150,287 $5.89 Million
Q3 2019

Nov 04, 2019
SELL
$32.49 - $42.13 $1.17 Million - $1.52 Million
-36,062 Reduced 18.79%
155,859 $5.6 Million
Q2 2019

Aug 06, 2019
SELL
$36.98 - $41.52 $268,105 - $301,020
-7,250 Reduced 3.64%
191,921 $8.31 Million
Q1 2019

May 01, 2019
SELL
$37.5 - $41.2 $450,300 - $494,729
-12,008 Reduced 5.69%
199,171 $8.46 Million
Q4 2018

Feb 06, 2019
SELL
$38.47 - $43.86 $29,314 - $33,421
-762 Reduced 0.36%
211,179 $9.22 Million
Q3 2018

Nov 07, 2018
BUY
$34.47 - $41.81 $655,205 - $794,724
19,008 Added 9.85%
211,941 $9.34 Million
Q2 2018

Aug 01, 2018
BUY
$32.98 - $35.16 $107,613 - $114,727
3,263 Added 1.72%
192,933 $7 Million
Q1 2018

May 07, 2018
BUY
$31.91 - $37.02 $70,297 - $81,555
2,203 Added 1.18%
189,670 $6.73 Million
Q4 2017

Feb 09, 2018
SELL
$33.26 - $35.29 $112,718 - $119,597
-3,389 Reduced 1.78%
187,467 $6.79 Million
Q3 2017

Nov 06, 2017
BUY
$31.0 - $34.15 $5.92 Million - $6.52 Million
190,856
190,856 $6.81 Million

Others Institutions Holding PFE

# of Institutions
3,260
Shares Held
3.73B
Call Options Held
73.5M
Put Options Held
108M
View Full List

About PFIZER INC

PFE Quotes by TradingView
  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $147B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Montag A & Associates Inc Portfolio

Follow Montag A & Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Montag A & Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Montag A & Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email